Novo Nordisk Slovakia s.r.o.

Active
IČO 36753050limited liability company (s.r.o.)Founded 2007Bratislava - mestská časť Ružinov

Key figures

67 995 112 €+14,5%
Revenue 2025
+25,3%
Average annual growth 2020–2025
020 m40 m60 m80 m202020212022202320242025

Key figures

2025

Dividends

calculated
2025

Distributed as dividends 1 600 000 € (83 % of distributable profit).

History
20251 600 000 €
2024999 999 €
2023700 000 €
2022485 001 €
2021350 001 €

Summary: Novo Nordisk Slovakia s.r.o.

What kind of company is it?

Novo Nordisk Slovakia s.r.o. (IČO 36753050) is a limited liability company (s.r.o.). The company was incorporated in 2007 and has existed for 19 years. Registered office according to the register: Bratislava - mestská časť Ružinov. Main activity according to the Statistical Office: veľkoobchod s farmaceutickým a zdravotníckym tovarom (SK NACE 4646). Size category by number of employees: 50–99 employees.

Who runs the company and who owns it?

The statutory body has 3 members. According to the register, the company has one shareholder. The registered capital is 265 552 €.

How is the company doing financially?

Revenue for 2025 was 67 995 112 €, up 14,5 % on the previous year (59 392 580 €). From 2020 to 2025, revenue grew by an average of 25,3 % per year. This is the highest revenue in the reported years (2020–2025). Net profit for 2025 was 1 767 121 € (2,6 % of revenue). The company was profitable in all 6 reported years. Personnel costs for 2025 were 5 882 359 €. At the end of 2025 the company had total assets of 13 114 114 € and equity of 2 439 852 € (equity ratio 18,6 %).

Where does the data come from and how current is it?

Company and people data come from the Register of Legal Entities (Statistical Office SR, CC BY 4.0) and financial statements from the Register of Financial Statements (Ministry of Finance SR); icoprofil.sk updates them daily. Data as of 18. 11. 2026. Changes, averages and ratios are calculated by icoprofil.sk from open data and are not an official assessment.

Summary of annual reports2020–2025
20212022202320242025
Revenue (net turnover)29 683 96540 521 11246 589 81759 392 58067 995 112
Profit for the reporting year439 864860 6231 131 5521 632 0101 767 121
Retained earnings of previous periods45 790653161 276292 829324 839
Total assets12 466 3007 167 1178 396 55311 618 45613 114 114
Total liabilities11 632 7545 957 9496 755 8339 345 72510 674 262
Total equity833 5461 209 1681 640 7202 272 7312 439 852
Calculated dividends350 001485 001700 000999 9991 600 000

A dash (—) means the report has not been filed or the line is not reported; 0 is a zero stated in the report.

Documents in the Register of Financial Statements13

Documents open directly on registeruz.sk (Ministry of Finance of the Slovak Republic).

Similar companies

Same industry (SK NACE 4646)
Novo Nordisk Slovakia s.r.o. (IČO 36753050) – revenue 68M €